Actelion Pharmaceuticals Ltd has an opening for an *M&S scientist/pharmacometrician* based in the Basel area (Switzerland).
If you are interested and qualified, please apply online: https://jobs.actelion.com/careersection/ex/jobdetail.ftl?job=160000KN *About The Company* Actelion Pharmaceuticals Ltd. is a leading biopharmaceutical company employing over 2,500 dedicated professionals covering all key markets around the world – including Europe, the US, Japan, China, Russia and Mexico. Headquartered in Allschwil near Basel, Switzerland, our functional, award-winning Actelion Center is a symbol of our innovative spirit and culture. We are searching for breakthrough medicines for high unmet medical needs and this inspires and motivates all of us to work towards achieving our overriding mission: to treat more patients with groundbreaking therapies. Besides highly competitive compensation and tangible benefits, would you like to have a noticeable impact and enjoy our culture of innovation, trust and teamwork? Do you want to grow in a different kind of company with an enthusiastic, stimulating environment fostered by open communication and a results-driven approach? Then we welcome your application to join our team in the role of *(Senior) Modeling and Simulation Scientist / Pharmacometrician* based in Allschwil. *Job Responsibilities* - Support compounds and projects in clinical development with model-based data analysis - Support decision making in clinical development by simulation of scenarios and studies - Contribute to decision making with quantitative assessments of efficacy and safety measures of different doses, dosing regimens, and other relevant variables - Identify opportunities for model-based drug development - Maintain effective communication with Life Cycle Team, Clinical Team, and Clinical Trial Team via the responsible (Senior) Clinical Pharmacologist-Coordinate team work within modeling and simulation - Ensure high quality contributions to drug development - Management of quality and timelines - Knowledge of relevant regulatory guidelines and requirements - Sustain scientific competence by establishing familiarity with new scientific developments - Education of colleagues in Clinical Pharmacology and Clinical Development about modeling and simulation *Candidate Requirements* - Relevant academic degree (pharmacology, statistics, pharmacometrics) with preference for a PhD level of education - 3+ years of experience in applying modeling and simulation to drug development - Good knowledge of drug development and the transition phases (preclinical to Phase I, Phase I to II) - Experience with relevant software (Monolix, R/S-PLUS, NONMEM, Berkeley Madonna) - Track record of relevant publications - Good interpersonal and communication skills - Natural curiosity to learn, phrase questions and share M&S approaches with other scientists - Scientific mind, interest in research, publications, and presentations *What Actelion Offers* - A competitive salary and generous social benefits - The possibility for development and advancement within our dynamic organization - The innovative and stimulating atmosphere of a multicultural environment The research facilities are located in Allschwil, Switzerland, a suburb of Basel on the borders of France and Germany. -- Andreas Krause, PhD Senior Director Data Management, Modeling and Simulation Department of Clinical Pharmacology Actelion Pharmaceuticals Ltd. • Gewerbestrasse 16 • CH-4123 Allschwil • Switzerland G06.05.W.16.2 andreas.kra...@actelion.com • www.actelion.com Address for visitors: Hegenheimermattweg 95 -- The information of this email and in any file transmitted with it is strictly confidential and may be legally privileged. It is intended solely for the addressee. If you are not the intended recipient, any copying, distribution or any other use of this email is prohibited and may be unlawful. In such case, you should please notify the sender immediately and destroy this email. The content of this email is not legally binding unless confirmed by letter. Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorized to state them to be the views of the sender's company.
